10P PIK3CA mutation and response to neoadjuvant taselisib and endocrine therapy: A biomarker study of the LORELEI trial

Fimereli, D. ; Nuciforo, P.G. ; de Azambuja, E. ; Wilson, T. ; Prat, A. ; Filipits, M. ; Pfeiler, G. ; Aimi, J. ; Metcalfe, C. ; Stout, T.J. ; El-Abed, S. ; Gnant, M.I. ; Oliveira, M. ; Vincent, D. ; Rediti, M. ; Rothé, F. ; Manich, C. Saura ; André, F. ; Sotiriou, C.

ESMO open, 2024-05, Vol.9, p.103019, Article 103019 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível